相似文献
1
Exploring the native human antibody repertoire to create antiviral therapeutics.
Curr Top Microbiol Immunol. 2008;317:155-83. doi: 10.1007/978-3-540-72146-8_6.
2
Antibodies for the prevention and treatment of viral diseases.
Antiviral Res. 2000 Aug;47(2):57-77. doi: 10.1016/s0166-3542(00)00111-x.
3
High efficiency creation of human monoclonal antibody-producing hybridomas.
J Immunol Methods. 2004 Aug;291(1-2):109-22. doi: 10.1016/j.jim.2004.05.005.
4
Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases.
Infect Agents Dis. 1993 Jun;2(3):118-31.
5
[Viral infection].
Nihon Rinsho. 2002 Mar;60(3):585-90.
6
Monoclonal antibody therapy and viral infections: update and beyond.
Clin Microbiol Infect. 2011 Dec;17(12):1757-8. doi: 10.1111/j.1469-0691.2011.03670.x. Epub 2011 Oct 19.
7
Recombinant monoclonal antibody technology.
Transfus Clin Biol. 2002 Jan;9(1):15-22. doi: 10.1016/s1246-7820(01)00210-5.
8
Polyclonal and monoclonal antibodies for the treatment of influenza.
Curr Opin Infect Dis. 2018 Dec;31(6):527-534. doi: 10.1097/QCO.0000000000000499.
9
Fc receptors in antibody-dependent enhancement of viral infections.
Immunol Rev. 2015 Nov;268(1):340-64. doi: 10.1111/imr.12367.
10
Antiviral antibodies in transplantation.
Transplant Proc. 1995 Oct;27(5 Suppl 1):10-2.
引用本文的文献
1
Discovery of high affinity anti-ricin antibodies by B cell receptor sequencing and by yeast display of combinatorial VH:VL libraries from immunized animals.
MAbs. 2016 Aug-Sep;8(6):1035-44. doi: 10.1080/19420862.2016.1190059. Epub 2016 May 25.
2
Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.
ACS Chem Biol. 2012 Jul 20;7(7):1139-51. doi: 10.1021/cb300119g. Epub 2012 Jul 3.
3
Prophylaxis and therapy for Chikungunya virus infection.
J Infect Dis. 2009 Aug 15;200(4):516-23. doi: 10.1086/600381.
本文引用的文献
1
Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy.
Int J Gynaecol Obstet. 2007 Mar;96(3):167-70. doi: 10.1016/j.ijgo.2006.11.011. Epub 2007 Feb 12.
2
New display vector reduces biological bias for expression of antibodies in E. coli.
Gene. 2007 Apr 15;391(1-2):120-9. doi: 10.1016/j.gene.2006.12.009. Epub 2006 Dec 22.
3
Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naïve and memory B cells.
Mol Immunol. 2007 Mar;44(9):2173-83. doi: 10.1016/j.molimm.2006.11.020. Epub 2006 Dec 29.
4
Hepatitis B in liver transplant recipients.
Liver Transpl. 2006 Nov;12(11 Suppl 2):S54-64. doi: 10.1002/lt.20950.
5
Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone.
Hepatol Res. 2006 Dec;36(4):265-71. doi: 10.1016/j.hepres.2006.08.001. Epub 2006 Sep 11.
6
Clinical aspects of parvovirus B19 infection.
J Intern Med. 2006 Oct;260(4):285-304. doi: 10.1111/j.1365-2796.2006.01697.x.
7
A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis.
Annu Rev Med. 2007;58:359-68. doi: 10.1146/annurev.med.58.061705.145053.
8
Understanding and making use of human memory B cells.
Immunol Rev. 2006 Jun;211(1):303-9. doi: 10.1111/j.0105-2896.2006.00403.x.
9
Antiviral drugs for cytomegalovirus diseases.
Antiviral Res. 2006 Sep;71(2-3):154-63. doi: 10.1016/j.antiviral.2006.05.002. Epub 2006 May 23.
10
Parvovirus B19 infection after transplantation: a review of 98 cases.
Clin Infect Dis. 2006 Jul 1;43(1):40-8. doi: 10.1086/504812. Epub 2006 May 12.
Zotero 插件